Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study
CONCLUSION: Darvadstrocel is a safe, minimally invasive surgical technique without significant perioperative complications. Clinical success can be expected in about half of the treated patients.PMID:37823920 | DOI:10.1007/s00508-023-02283-4
Source: Wiener Klinische Wochenschrift - Category: General Medicine Authors: Christopher Dawoud Kerstin Melanie Widmann Sascha Czipin Michael Pramhas Martina Scharitzer Anton Stift Felix Harpain Stefan Riss Source Type: research
More News: Austria Health | Crohn's Disease | General Medicine | Humira | Inflammatory Bowel Disease | Remicade | Stelara | Stem Cell Therapy | Stem Cells | Study